Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
314 Leser
Artikel bewerten:
(1)

Bracco Group: Bracco and Zereau Join Forces for Innovative Research Program Aimed at Improving Sustainability in Medical Imaging

The two companies announced the launch of a study to reduce contrast media in wastewater through sustainable urine filtration systems for hospitals and diagnostic facilities

MILAN, Feb. 26, 2025 /PRNewswire/ -- Bracco Imaging SpA, a world leader in diagnostic imaging and Zereau BV, a provider of unique water technology for the healthcare sector, announced today they have signed an agreement to launch the second stage of a groundbreaking research program aimed at improving the sustainability of medical imaging.

Bracco Diagnostics Inc.

This new stage of the research program, entitled "The Water Project," focuses on the development and testing of scalable, robust urine collection and filtration devices with the goal of integrating a sustainable solution into hospital radiology departments. Patients receiving contrast media in hospitals and diagnostic facilities will use special toilets designed to collect and filter the contrast from their urine. Once saturated, these filters will be collected and processed by third-party partners to recover raw materials such as iodine, which would otherwise be released into wastewater. This study follows the successful completion of an earlier study that evaluated the performance of a urine filtration system for iodinated contrast media.

The announcement occurs on the first day of the European Congress of Radiology, taking place in Vienna from February 26 to March 2, which is focused on greater sustainability in radiology this year. The innovative filtration system for contrast media will be presented at the Bracco booth (Foyer E, Level 0, ACV) at ECR. The full program is available here.

By addressing water quality preservation and resource recovery, this initiative creates a circular economy model that aligns with Bracco's commitment to sustainable healthcare solutions and environmental stewardship. The collaboration with Zereau, which brings technical expertise in water filtration technology and innovative sanitary solutions to this project, is a significant step toward minimizing the environmental footprint of contrast media use in medical imaging.

"As a leader in medical imaging, Bracco recognizes that sustainability and innovation must go hand in hand and we are motivated by a responsibility to drive meaningful change," said Erik Bruno, Innovation for Sustainability Manager, Bracco Imaging. "Through the partnership with Zereau, we are leveraging our shared expertise to work toward industry-wide transformation in reducing waste, which remains one of the biggest challenges in medical imaging."

"We're very excited that our groundbreaking technology and vision for clean water and raw materials recovery in healthcare are gaining recognition through our partnership with Bracco," said Mattijs Maris, CCO of Zereau. "We're ready to scale up, revolutionize radiology with our water filter systems, and drive a more circular, sustainable healthcare sector with Bracco."

About Bracco Imaging
Bracco Imaging is a global leader in diagnostic imaging, providing advanced imaging agents and state-of-the-art delivery systems across a wide range of modalities, including X-ray, MRI, Nuclear Medicine, and Ultrasound. With a legacy of innovation and a commitment to improving patient outcomes, Bracco continues to pioneer technologies that enhance diagnostic accuracy and transform patient care.

About Zereau
Zereau creates revolutionary water technology for healthcare institutions, with a focus on sanitary filter solutions at the source, specific patient groups and hospital departments. A source-based approach efficiently reduces specific medical micropollutants enter the environment and opens prospects for circularity of valuable raw materials. Zereau provides solutions for e.g. radiology, nuclear medicine, ICUs, hospital pharmacies and oncology departments.

Bracco Press Contact:
Carolina Bargoni
Bracco Imaging, Communications Director
Carolina.bargoni@bracco.com
+39 347 5397738

Zereau Press Contact:
Mattijs Maris
Chief Commercial Officer, Zereau BV
m.maris@zereau.com
+ 31 6 2242 7052

Zereau Logo

Logo - https://mma.prnewswire.com/media/1707756/Bracco_Diagnostics_Logo_Logo.jpg
Logo - https://mma.prnewswire.com/media/2625165/Zereau_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/bracco-and-zereau-join-forces-for-innovative-research-program-aimed-at-improving-sustainability-in-medical-imaging-302384830.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.